Next report date
Report period
Q4 2023
EPS estimate
−0.11USD
Revenue estimate
200.00 KUSD
−0.3825USD
−14.14 MUSD
77.04 KUSD
14.85 M
About Nemaura Medical, Inc.
Sector
Industry
CEO
Dewan Fazlul Hoque Chowdhury
Website
Headquarters
New York
Employees (FY)
38
Founded
2013
FIGI
BBG0068FC7X9
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NMRD is 0.0699 USD — it has increased by 7.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nemaura Medical, Inc. stocks are traded under the ticker NMRD.
Nemaura Medical, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
NMRD stock is 31.64% volatile and has beta coefficient of 0.64. Check out the list of the most volatile stocks — is Nemaura Medical, Inc. there?
NMRD earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.11 USD resulting in a 63.64% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Nemaura Medical, Inc. earnings.
Yes, you can track Nemaura Medical, Inc. financials in yearly and quarterly reports right on TradingView.
NMRD stock has fallen by 4.25% compared to the previous week, the month change is a 13.17% fall, over the last year Nemaura Medical, Inc. has showed a 91.34% decrease.
NMRD net income for the last quarter is −2.16 M USD, while the quarter before that showed −1.20 M USD of net income which accounts for −79.61% change. Track more Nemaura Medical, Inc. financial stats to get the full picture.
Today Nemaura Medical, Inc. has the market capitalization of 1.88 M, it has decreased by 2.83% over the last week.
No, NMRD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NMRD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nemaura Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 38.00 employees. See our rating of the largest employees — is Nemaura Medical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nemaura Medical, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nemaura Medical, Inc. stock shows the sell signal. See more of Nemaura Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Nemaura Medical, Inc. future price: according to them, NMRD price has a max estimate of 1.50 USD and a min estimate of 1.50 USD. Read a more detailed Nemaura Medical, Inc. forecast: see what analysts think of Nemaura Medical, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nemaura Medical, Inc. EBITDA is −8.82 M USD, and current EBITDA margin is −10.23 K%. See more stats in Nemaura Medical, Inc. financial statements.